What does Raltegravir (Isentress) do in plain English—and how does it work inside your body?
Raltegravir is an FDA-regulated Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor (RxNorm RxCUI 744842). Mechanistically, 12.1 Mechanism of Action Raltegravir is an HIV-1 antiviral drug . As an active human immunodeficiency virus integrase strand transfer inhibitor moiety (Camber Pharmaceuticals, Inc.), Raltegravir modulates physiological signaling proportional to 400 mg/1 Tablet, Film Coated exposure and hepatorenal clearance (SPL 2026-07-04). [1][2].
When your doctor writes a prescription for Raltegravir (RxNorm RxCUI 744842, also dispensed under brand names including Isentress), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, 12.1 Mechanism of Action Raltegravir is an HIV-1 antiviral drug . As an active human immunodeficiency virus integrase strand transfer inhibitor moiety (Camber Pharmaceuticals, Inc.), Raltegravir modulates physiological signaling proportional to 400 mg/1 Tablet, Film Coated exposure and hepatorenal clearance (SPL 2026-07-04). [2].
Across real-world patient logs on dotMD (77% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Raltegravir tablet bottle and confirm with your pharmacist that it matches your prescribed strength (400 mg/1 Tablet, Film Coated, 100 mg/1 Tablet, Chewable, 25 mg/1 Tablet, Chewable, 100 mg/1 Granule, for Suspension, 600 mg/1 Tablet, Film Coated).